Chemical inhibitors of CstF-64T can interfere with the protein's function by targeting the processes that are integral to its activity. Cordycepin, for example, mirrors adenosine in structure and acts as a chain terminator during mRNA synthesis. The incorporation of cordycepin into the growing RNA chain halts further elongation, which in turn prevents the maturation of pre-mRNA, a process that requires the action of CstF-64T for 3' end cleavage and polyadenylation. Similarly, α-Amanitin exerts its inhibitory effects by binding to and incapacitating RNA polymerase II, the enzyme responsible for transcribing mRNA. This results in a substantial decrease in the pool of nascent pre-mRNA available for further processing by CstF-64T. On the same lines, DRB and Flavopiridol inhibit cyclin-dependent kinases like CDK9 and CDK7, which are vital for the phosphorylation of RNA polymerase II, a necessary step for transcriptional elongation. The consequent reduction in mRNA transcription indirectly restricts the activity of CstF-64T.
Further, Triptolide non-selectively obstructs transcriptional activity by hindering transcription factors, thus diminishing the synthesis of pre-mRNA substrates necessary for CstF-64T function. Mycophenolic Acid, through its inhibition of inosine monophosphate dehydrogenase, leads to a depletion of guanine nucleotides, which are essential for RNA synthesis, and therefore, indirectly impairs the function of CstF-64T. Actinomycin D and Distamycin A disrupt the transcription initiation complex and transcription factor binding to DNA, respectively, which results in a decreased production of mRNA for CstF-64T to act upon. Camptothecin's inhibition of DNA topoisomerase I limits the availability of relaxed DNA, which is required for transcription, and as a result, for CstF-64T activity. Additionally, α-Sarcin and Ricin induce cellular stress responses that can lead to a reduction in transcription and RNA processing, thus indirectly reducing CstF-64T function. Lastly, Homoharringtonine inhibits protein synthesis, which can cause cellular stress responses that potentially downregulate RNA processing pathways, including those involving CstF-64T. Each of these chemicals, by disrupting specific stages of mRNA synthesis and processing, can functionally inhibit the activity of CstF-64T.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $101.00 | 5 | |
Cordycepin terminates mRNA synthesis by acting as a chain terminator due to its structural similarity to adenosine. This can inhibit CstF-64T by preventing the completion of pre-mRNA that requires 3' end processing. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
α-Amanitin inhibits RNA polymerase II, which is essential for the synthesis of mRNA. By inhibiting RNA polymerase II, α-Amanitin can reduce the availability of pre-mRNA substrates for CstF-64T to act on. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
DRB inhibits cyclin-dependent kinases like CDK9 that are required for transcription elongation. Inhibiting these kinases can indirectly inhibit CstF-64T by limiting the pool of mRNA transcripts available for cleavage and polyadenylation. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $259.00 | 41 | |
Flavopiridol inhibits CDK9 and CDK7, which are required for RNA polymerase II transcription. Reduced transcription results in fewer pre-mRNA substrates for CstF-64T function. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide inhibits transcriptional activity by affecting multiple transcription factors. This leads to reduced pre-mRNA levels and thus, indirectly inhibits the function of CstF-64T. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $69.00 $266.00 | 8 | |
Mycophenolic Acid inhibits inosine monophosphate dehydrogenase, leading to a depletion of guanine nucleotides and consequently reducing RNA synthesis, indirectly inhibiting CstF-64T. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D binds DNA at the transcription initiation complex and prevents elongation by RNA polymerase, thereby reducing mRNA synthesis and indirectly inhibiting CstF-64T. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin inhibits DNA topoisomerase I, which is necessary for DNA unwinding during transcription. This inhibition can reduce the production of pre-mRNA, thereby inhibiting CstF-64T activity. | ||||||
α-Sarcin | 86243-64-3 | sc-204427 | 1 mg | $462.00 | 6 | |
α-Sarcin can induce stress responses that may downregulate transcription and RNA processing pathways, indirectly inhibiting the function of CstF-64T. | ||||||
Homoharringtonine | 26833-87-4 | sc-202652 sc-202652A sc-202652B | 1 mg 5 mg 10 mg | $52.00 $125.00 $182.00 | 11 | |
Homoharringtonine inhibits protein synthesis which can lead to cellular stress and potentially downregulate RNA processing pathways, indirectly inhibiting CstF-64T. | ||||||